A new way of human-computer interaction is unveiled by Microsoft

The potential of genetically modified food to combat health problems in the developing world is being hamstrung by misguided legislation and backward thinking

Exploring the science behind social dynamics

Chairman Barrett retiring after 35 years with company director Jane Shaw taking over

Besides producing carefully adapted artificial limbs to change the lives of disabled people, the world’s only major listed prosthetics maker is also looking ahead to the day when robotics and neuroscience can change those of many more

Just a few steps from the monastery where Gregor Mendel pioneered the field of genetics some 150 years ago, Czech officials hope to nurture their own biotech revolution

As regulators around the world get tougher on money laundering, banks are increasingly looking for software solutions to spot criminal transactions

Generic pharma companies can offer bioequivalent products at a fraction of the price. So why do brand names continue to sell after patent expiry?

Small Thai firms are taking on the giants over the production of generic versions of potential lifesaving drugs. And this time they have government backing

Telepresence is tipped to become the norm for international business, but will it fulfil the promise of ubiquity?

The UK has no tolerance for GM crops in the food chain, but will it accept using them to produce drugs?

With technology and interest growing steadily, will embryonic stem cell research head a medical revolution?